Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Aurobindo Pharma Limited
FDA Inspection
•Aurobindo Pharma Limited•March 16, 2018

Aurobindo Pharma Limited – FDA Inspection, Mar 16, 2018

Record Details

This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on March 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Aurobindo Pharma Limited
Inspection Date
March 16, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Debra I. Love (FDA Associated Person)
  • Philip F. Istafanos (Issuing Officer)
View Company Profile

ID · d4cc3587-20be-4443-8712-6e49c304278b

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1046218
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

2
  1. 21 CFR 211.194(a)(4)Complete Test Data
  2. 21 CFR 211.113(b)Procedures for sterile drug products

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Aurobindo Pharma Limited

7
DateClassificationOfficeProject area
September 5, 2025OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 9, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 21, 2020VAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
August 16, 2013NAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
June 26, 2012VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Aurobindo Pharma Limited
  • FDA Inspection 1286862 - 2025-09-05
  • FDA Inspection 1241780 - 2023-03-09
  • FDA Inspection 1118385 - 2020-02-21
  • FDA Inspection 847151 - 2013-08-16
  • FDA Inspection 793023 - 2012-06-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aurobindo Pharma Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.